Gene · 3918
Papers2,268
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
261 to 280 of 2,268
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Machine learning approach to screen new diagnostic features of adamantinomatous craniopharyngioma and explore personalised treatment strategies. | Transl Pediatr | 2023 | 37305719 | PubTator, text mining | PubMed |
| A Comprehensive Transcriptional Signature in Pancreatic Ductal Adenocarcinoma Reveals New Insights into the Immune and Desmoplastic Microenvironments. | Cancers (Basel) | 2023 | 37296850 | PubTator, text mining | PubMed |
| Cellular and Molecular Mechanisms of Liver Fibrosis in Patients with NAFLD. | Cancers (Basel) | 2023 | 37296834 | PubTator, text mining | PubMed |
| IGFBP1 Sustains Cell Survival during Spatially-Confined Migration and Promotes Tumor Metastasis. | Adv Sci (Weinh) | 2023 | 37296072 | PubTator, text mining | PubMed |
| Primary testicular lymphoma demonstrates overexpression of the Wilms tumor 1 gene and different mRNA and miRNA expression profiles compared to nodal diffuse large B-cell lymphoma. | Hematol Oncol | 2023 | 37291944 | PubTator, text mining | PubMed |
| Little things with significant impact: miRNAs in hepatocellular carcinoma. | Front Oncol | 2023 | 37274242 | PubTator, text mining | PubMed |
| m6A-mediated upregulation of LINC01003 regulates cell migration by targeting the CAV1/FAK signaling pathway in glioma. | Biol Direct | 2023 | 37270527 | PubTator, text mining | PubMed |
| Molecular Characterization and Landscape of Breast cancer Models from a multi-omics Perspective. | J Mammary Gland Biol Neoplasia | 2023 | 37269418 | PubTator, text mining | PubMed |
| Targeting protein glycosylation to regulate inflammation in the respiratory tract: novel diagnostic and therapeutic candidates for chronic respiratory diseases. | Front Immunol | 2023 | 37256139 | PubTator, text mining | PubMed |
| Amelogenesis imperfecta: Next-generation sequencing sheds light on Witkop's classification. | Front Physiol | 2023 | 37228816 | PubTator, text mining | PubMed |
| Reprogramming of glucose metabolism via PFKFB4 is critical in FGF16-driven invasion of breast cancer cells. | Biosci Rep | 2023 | 37222403 | PubTator, text mining | PubMed |
| Harnessing cancer stem cell-derived exosomes to improve cancer therapy. | J Exp Clin Cancer Res | 2023 | 37217932 | PubTator, text mining | PubMed |
| Synthetic Epigenetic Reprogramming of Mesenchymal to Epithelial States Using the CRISPR/dCas9 Platform in Triple Negative Breast Cancer. | Adv Sci (Weinh) | 2023 | 37217832 | PubTator, text mining | PubMed |
| Function and prognostic value of basement membrane -related genes in lung adenocarcinoma. | Front Pharmacol | 2023 | 37214471 | PubTator, text mining | PubMed |
| Identification of the key miRNA-mRNA regulatory network in lung adenocarcinoma. | J Thorac Dis | 2023 | 37197496 | PubTator, text mining | PubMed |
| Single-cell transcriptomics of human-skin-equivalent organoids. | Cell Rep | 2023 | 37195865 | PubTator, text mining | PubMed |
| Precancerous Lesions of the Head and Neck Region and Their Stromal Aberrations: Piecemeal Data. | Cancers (Basel) | 2023 | 37190121 | PubTator, text mining | PubMed |
| Serine Metabolic Reprogramming in Tumorigenesis, Tumor Immunity, and Clinical Treatment. | Adv Nutr | 2023 | 37187454 | PubTator, text mining | PubMed |
| Silencing of LAMC2 Reverses Epithelial Mesenchymal Transition and Inhibits Progression in Pancreatic Ductal Adenocarcinoma via Inactivation of the NF-κB Signaling Pathway. | Crit Rev Eukaryot Gene Expr | 2023 | 37183943 | PubTator, text mining | PubMed |
| Integrated analysis revealed hypoxia signatures and LDHA related to tumor cell dedifferentiation and unfavorable prognosis in pancreatic adenocarcinoma: Hypoxia in PDAC. | Transl Oncol | 2023 | 37182509 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3918/papers?page=14